USPTO trademark

Alexion Pharmaceuticals, Inc design mark 99221227

AllowedUSPTOFigurative markClass 5

"Design mark 99221227" is a figurative mark owned by Alexion Pharmaceuticals, Inc., filed at the USPTO on June 6, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

View Alexion Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
Alexion Pharmaceuticals, Inc design mark 99221227 trademark as filed
As filed with the USPTO
Status
Allowed
Since June 8, 2026
Filed
June 6, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99221227
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
1 class
Ownership

Who owns Alexion Pharmaceuticals, Inc design mark 99221227

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Alexion Pharmaceuticals, Inc.

ALXN · Boston, United States

208 trademarks in the portfolioView company

Representative

Leonid Rakitin

AstraZeneca Pharmaceuticals LP

Goods and services

What the mark covers

The products and services Alexion Pharmaceuticals, Inc design mark 99221227 is filed for, grouped by Nice class.

  • Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Vaccines

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Notice of approval of extension request e-mailed
  5. Sou extension 1 granted
  6. Sou extension 1 filed
  7. Sou teas extension received
  8. Noa e-mailed - sou required from applicant
  9. Post publication amendment reviewed – no action taken
  10. Assigned to petition staff

10 earlier steps on the official record.

FAQ

About Alexion Pharmaceuticals, Inc design mark 99221227

Who owns the trademark "Design mark 99221227"?

The USPTO trademark "Design mark 99221227" (application 99221227) is owned by Alexion Pharmaceuticals, Inc.

What is the status of "Design mark 99221227"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Alexion Pharmaceuticals, Inc design mark 99221227 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2ad9-2370-76a2-a11a-4107a62f0531
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2ad9-2370-76a2-a11a-4107a62f0531",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99221227",
  "filing_date": "2025-06-06",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Alexion Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb70a-13c6-766b-b4ec-ed9ff6c116be"
    }
  ]
}